Bender Robert & Associates Johnson & Johnson Transaction History

Bender Robert & Associates

$471 Million
Q3 2024

A detailed history of Bender Robert & Associates transactions in Johnson & Johnson stock. As of the latest transaction made, Bender Robert & Associates holds 3,539 shares of JNJ stock, worth $511,279. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,539

Previous 3,578 1.09%

Holding current value

$511,279

Previous $522,000 9.77%

% of portfolio

0.12%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$145.48 - $167.38 $514,853 - $592,357	3,539 New	3,539 $573,000
Q1 2024 Apr 22, 2024	SELL	$155.22 - $162.74 $63,950 - $67,048	-412 Reduced 8.95%	4,189 $662,000
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $14,560 - $15,888	-100 Reduced 2.13%	4,601 $721,000
Q3 2023 Oct 13, 2023	SELL	$155.75 - $174.48 $63,546 - $71,187	-408 Reduced 7.99%	4,701 $732,000
Q2 2023 Jul 13, 2023	SELL	$154.35 - $166.11 $65,135 - $70,098	-422 Reduced 7.63%	5,109 $845,000
Q1 2023 Apr 20, 2023	BUY	$151.05 - $180.26 $5,135 - $6,128	34 Added 0.62%	5,531 $857,000
Q4 2022 Feb 02, 2023	SELL	$160.2 - $179.79 $1,602 - $1,797	-10 Reduced 0.18%	5,497 $971,000
Q3 2022 Oct 26, 2022	BUY	$161.33 - $179.52 $64,532 - $71,808	400 Added 7.83%	5,507 $900,000
Q1 2022 Apr 14, 2022	BUY	$158.14 - $179.59 $19,134 - $21,730	121 Added 2.43%	5,107 $905,000
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $4.32 Million - $4.8 Million	-26,725 Reduced 84.28%	4,986 $805,000
Q3 2021 Nov 03, 2021	BUY	$161.5 - $179.47 $4.31 Million - $4.79 Million	26,690 Added 531.57%	31,711 $31.5 Million
Q2 2021 Jul 16, 2021	BUY	$159.48 - $171.07 $5,581 - $5,987	35 Added 0.7%	5,021 $827,000
Q2 2020 Jul 31, 2020	SELL	$128.81 - $155.51 $3,864 - $4,665	-30 Reduced 0.6%	4,986 $701,000
Q1 2020 Apr 21, 2020	SELL	$111.14 - $153.99 $3,334 - $4,619	-30 Reduced 0.59%	5,016 $658,000
Q2 2019 Jul 30, 2019	BUY	$131.15 - $144.24 $8,524 - $9,375	65 Added 1.3%	5,046 $660,000
Q1 2019 Apr 30, 2019	BUY	$125.72 - $139.79 $18,355 - $20,409	146 Added 3.02%	4,981 $696,000
Q4 2018 Jan 24, 2019	SELL	$122.84 - $147.84 $3,071 - $3,696	-25 Reduced 0.51%	4,835 $624,000
Q3 2018 Oct 17, 2018	SELL	$121.58 - $142.88 $607 - $714	-5 Reduced 0.1%	4,860 $672,000
Q2 2018 Jul 27, 2018	BUY	$119.4 - $131.76 $7,164 - $7,905	60 Added 1.25%	4,865 $590,000
Q1 2018 Apr 27, 2018	SELL	$125.1 - $148.14 $71,932 - $85,180	-575 Reduced 10.69%	4,805 $616,000
Q4 2017 Jan 19, 2018	SELL	$131.22 - $143.62 $22,176 - $24,271	-169 Reduced 3.05%	5,380 $752,000
Q3 2017 Oct 23, 2017	BUY	$129.47 - $135.38 $718,429 - $751,223	5,549	5,549 $721,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Account

Bender Robert & Associates Johnson & Johnson Transaction History